250 related articles for article (PubMed ID: 19544202)
1. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction.
Cetin I; Cozzi V; Papageorghiou AT; Maina V; Montanelli A; Garlanda C; Thilaganathan B
Acta Obstet Gynecol Scand; 2009; 88(7):846-9. PubMed ID: 19544202
[TBL] [Abstract][Full Text] [Related]
2. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
[TBL] [Abstract][Full Text] [Related]
3. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia.
Rovere-Querini P; Antonacci S; Dell'Antonio G; Angeli A; Almirante G; Cin ED; Valsecchi L; Lanzani C; Sabbadini MG; Doglioni C; Manfredi AA; Castiglioni MT
Obstet Gynecol; 2006 Jul; 108(1):148-55. PubMed ID: 16816069
[TBL] [Abstract][Full Text] [Related]
4. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R; Casagrandi D; Livanos P; Tetteh A; Nicolaides KH
Prenat Diagn; 2009 Oct; 29(10):934-8. PubMed ID: 19565609
[TBL] [Abstract][Full Text] [Related]
5. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
7. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery.
Assi F; Fruscio R; Bonardi C; Ghidini A; Allavena P; Mantovani A; Locatelli A
BJOG; 2007 Feb; 114(2):143-7. PubMed ID: 17305891
[TBL] [Abstract][Full Text] [Related]
9. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
10. Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restriction.
Rang S; van Montfrans GA; Wolf H
Am J Obstet Gynecol; 2008 May; 198(5):519.e1-9. PubMed ID: 18279824
[TBL] [Abstract][Full Text] [Related]
11. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
[TBL] [Abstract][Full Text] [Related]
12. The expression of connective tissue growth factor in pregnancies complicated by severe preeclampsia or fetal growth restriction.
Oh SY; Song SE; Seo ES; Kim KH; Choi SJ; Suh YL; Sadovsky Y; Roh CR
Placenta; 2009 Nov; 30(11):981-7. PubMed ID: 19762080
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.
Laigaard J; Sørensen T; Placing S; Holck P; Fröhlich C; Wøjdemann KR; Sundberg K; Shalmi AC; Tabor A; Nørgaard-Pedersen B; Ottesen B; Christiansen M; Wewer UM
Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630
[TBL] [Abstract][Full Text] [Related]
14. [Expression of pentraxin-3 in placentas and its relationship with severe preeclampsia].
Zhou P; Luo X; Qi HB
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):347-50. PubMed ID: 22883522
[TBL] [Abstract][Full Text] [Related]
15. Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia.
Torricelli M; Sabatini L; Florio P; Scaccia V; Voltolini C; Biliotti G; De Bonis M; Petraglia F
J Matern Fetal Neonatal Med; 2009 Nov; 22(11):993-9. PubMed ID: 19900037
[TBL] [Abstract][Full Text] [Related]
16. The association between pentraxin 3 in maternal circulation and pathological intrauterine fetal growth restriction.
Ibrahim MI; Ammar EM; Ramy A; Ellaithy MI; Abdelrahman RM; Elkabarity R
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():1-8. PubMed ID: 25496843
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic growth factors and their receptors in first-trimester human decidua of pregnancies further complicated by preeclampsia or fetal growth restriction.
Plaisier M; Streefland E; Koolwijk P; van Hinsbergh VW; Helmerhorst FM; Erwich JJ
Reprod Sci; 2008 Sep; 15(7):720-6. PubMed ID: 18562698
[TBL] [Abstract][Full Text] [Related]
18. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction.
Valdés ER; Lattes KA; Muñoz HS; Barja PY; Papapietro KV
Gynecol Obstet Invest; 2011; 72(3):152-6. PubMed ID: 21912074
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
20. Follicular fluid levels of the long pentraxin PTX3.
Paffoni A; Ragni G; Doni A; Somigliana E; Pasqualini F; Restelli L; Pardi G; Mantovani A; Garlanda C
J Soc Gynecol Investig; 2006 Apr; 13(3):226-31. PubMed ID: 16516502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
